RXR modulators (Ligand/Lilly)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRXR modulators (Ligand/Lilly)
Drug Alias NameLGD-1069 analogs (Ligand/Lilly)RXR modulators (Ligand/Lilly)retinoid X receptor modulators (Ligand/Lilly)RXR modulators (Ligand)retinoid X receptor modulators (Ligand) +[9] 
ClassificationSmall molecules
Mechanisms of ActionInsulin sensitizersRetinoid X receptor modulators
TargetsRetinoid X receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLigand Pharmaceuticals IncEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A